Rheumatology Advance Access originally published online on September 7, 2004
Rheumatology 2004 43(12):1565-1568; doi:10.1093/rheumatology/keh386
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology Vol. 43 No. 12 © British Society for Rheumatology 2004; all rights reserved
PAPER |
A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis
Rheumatology, Bristol Royal Infirmary, Bristol and 1 Rheumatology, Royal Cornwall Hospital, Truro, Cornwall, UK.
Correspondence to: L. P. Robertson. E-mail: lindsay.robertson{at}ubht.swest.nhs.uk
Objective. To evaluate changes in functional status and disease activity and their determinants in patients with ankylosing spondylitis (AS) attending hospital, using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional Index (BASFI).
Methods. Patients completed BASDAI and BASFI questionnaires annually from 1996 to 2001. Demographic and clinical data were collected. The mean first and last recorded scores were compared. The change per year and area under the curve per year for the BASDAI and BASFI were calculated. Relationships between demographic, clinical and longitudinal BASDAI/BASFI data were examined. Subgroup analyses were performed using the cross-sectional and longitudinal data.
Results. Two hundred and seventy-nine BASDAI and 322 BASFI questionnaires were analysed. The BASFI increased [mean change 6.15, 95% confidence interval (CI) 1.9, 10.3, P = 0.005] but the BASDAI did not (mean change 0.87, 95% CI –3.96, 5.7, P = 0.71). First recorded scores were the best predictors of the cumulative scores per year. Patients with peripheral joint (P = 0.01) and hip (P<0.001) disease had higher mean BASFI scores. Males (P<0.001) and patients with spinal disease alone (P = 0.0014), iritis (P = 0.005) and late-onset AS (P = 0.002) became more functionally impaired over time.
Conclusions. Disease activity in this AS cohort remained relatively constant but there was functional decline. Initial BASDAI/FI can predict a severe disease course. PJD patients with peripheral joint disease were more functionally impaired, but deteriorated less than spinal disease alone patients. Iritis and late onset disease may be severity markers for functional impairment.
KEY WORDS: Ankylosing spondylitis, BASDAI, BASFI
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. A. Stone, E. Pomeroy, A. Keat, R. Sengupta, S. Hickey, P. Dieppe, R. Gooberman-Hill, R. Mogg, J. Richardson, and R. D. Inman Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration Rheumatology, August 1, 2008; 47(8): 1213 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Pradeep, A. Keat, and K. Gaffney Predicting outcome in ankylosing spondylitis Rheumatology, July 1, 2008; 47(7): 942 - 945. [Full Text] [PDF]
|
|
|
|
|
|
R. M. Ara, A. V. Reynolds, and P. Conway The cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in the UK Rheumatology, August 1, 2007; 46(8): 1338 - 1344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Martindale, J. Smith, C. J. Sutton, D. Grennan, L. Goodacre, and J. A. Goodacre Disease and psychological status in ankylosing spondylitis Rheumatology, October 1, 2006; 45(10): 1288 - 1293. [Abstract] [Full Text] [PDF]
|
|